Akums Drugs &Pharma, a prominent contract development and manufacturing company in India, launched an ₹1,856-crore IPO with ₹680 crore in fresh issuance. Promoters reduced stakes, and proceeds will tackle debt and working capital. Generating ₹4,178 crore in FY24, Akums serves top pharma brands and stands strong in the expanding market.
Cochin Shipyard shares surge 10% on FTSE index inclusion, may see $30 mn inflows
The shares have advanced by an impressive 246% over the last year, while in the past six months, the stock has surged by 110%. Year-to-date,